Cardiac dysfunction in patients affected by subarachnoid haemorrhage affects in-hospital mortality : A systematic review and metanalysis
Copyright © 2023 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited..
BACKGROUND: Subarachnoid haemorrhage (SAH) is a life-threatening condition with associated brain damage. Moreover, SAH is associated with a massive release of catecholamines, which may promote cardiac injury and dysfunction, possibly leading to haemodynamic instability, which in turn may influence a patient's outcome.
OBJECTIVES: To study the prevalence of cardiac dysfunction (as assessed by echocardiography) in patients with SAH and its effect on clinical outcomes.
DESIGN: Systematic review of observational studies.
DATA SOURCES: We performed a systematic search over the last 20 years on MEDLINE and EMBASE databases.
ELIGIBILITY CRITERIA: Studies reporting echocardiography findings in adult patients with SAH admitted to intensive care. Primary outcomes were in-hospital mortality and poor neurological outcome according to the presence or absence of cardiac dysfunction.
RESULTS: We included a total of 23 studies (4 retrospective) enrolling 3511 patients. The cumulative frequency of cardiac dysfunction was 21% (725 patients), reported as regional wall motion abnormality in the vast majority of studies (63%). Due to the heterogeneity of clinical outcome data reporting, a quantitative analysis was carried out only for in-hospital mortality. Cardiac dysfunction was associated with a higher in-hospital mortality [odds ratio 2.69 (1.64 to 4.41); P < 0.001; I2 = 63%]. The GRADE of evidence assessment resulted in very low certainty of evidence.
CONCLUSION: About one in five patients with SAH develops cardiac dysfunction, which seems to be associated with higher in-hospital mortality. The consistency of cardiac and neurological data reporting is lacking, reducing the comparability of the studies in this field.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
European journal of anaesthesiology - 40(2023), 6 vom: 01. Juni, Seite 442-449 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Messina, Antonio [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 04.05.2023 Date Revised 02.08.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1097/EJA.0000000000001829 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM35556422X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM35556422X | ||
003 | DE-627 | ||
005 | 20231226064620.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/EJA.0000000000001829 |2 doi | |
028 | 5 | 2 | |a pubmed24n1185.xml |
035 | |a (DE-627)NLM35556422X | ||
035 | |a (NLM)37052065 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Messina, Antonio |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cardiac dysfunction in patients affected by subarachnoid haemorrhage affects in-hospital mortality |b A systematic review and metanalysis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.05.2023 | ||
500 | |a Date Revised 02.08.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited. | ||
520 | |a BACKGROUND: Subarachnoid haemorrhage (SAH) is a life-threatening condition with associated brain damage. Moreover, SAH is associated with a massive release of catecholamines, which may promote cardiac injury and dysfunction, possibly leading to haemodynamic instability, which in turn may influence a patient's outcome | ||
520 | |a OBJECTIVES: To study the prevalence of cardiac dysfunction (as assessed by echocardiography) in patients with SAH and its effect on clinical outcomes | ||
520 | |a DESIGN: Systematic review of observational studies | ||
520 | |a DATA SOURCES: We performed a systematic search over the last 20 years on MEDLINE and EMBASE databases | ||
520 | |a ELIGIBILITY CRITERIA: Studies reporting echocardiography findings in adult patients with SAH admitted to intensive care. Primary outcomes were in-hospital mortality and poor neurological outcome according to the presence or absence of cardiac dysfunction | ||
520 | |a RESULTS: We included a total of 23 studies (4 retrospective) enrolling 3511 patients. The cumulative frequency of cardiac dysfunction was 21% (725 patients), reported as regional wall motion abnormality in the vast majority of studies (63%). Due to the heterogeneity of clinical outcome data reporting, a quantitative analysis was carried out only for in-hospital mortality. Cardiac dysfunction was associated with a higher in-hospital mortality [odds ratio 2.69 (1.64 to 4.41); P < 0.001; I2 = 63%]. The GRADE of evidence assessment resulted in very low certainty of evidence | ||
520 | |a CONCLUSION: About one in five patients with SAH develops cardiac dysfunction, which seems to be associated with higher in-hospital mortality. The consistency of cardiac and neurological data reporting is lacking, reducing the comparability of the studies in this field | ||
650 | 4 | |a Systematic Review | |
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Longhitano, Yaroslava |e verfasserin |4 aut | |
700 | 1 | |a Zanza, Christian |e verfasserin |4 aut | |
700 | 1 | |a Calabrò, Lorenzo |e verfasserin |4 aut | |
700 | 1 | |a Villa, Federico |e verfasserin |4 aut | |
700 | 1 | |a Cammarota, Gianmaria |e verfasserin |4 aut | |
700 | 1 | |a Sanfilippo, Filippo |e verfasserin |4 aut | |
700 | 1 | |a Cecconi, Maurizio |e verfasserin |4 aut | |
700 | 1 | |a Robba, Chiara |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of anaesthesiology |d 1993 |g 40(2023), 6 vom: 01. Juni, Seite 442-449 |w (DE-627)NLM012914576 |x 1365-2346 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2023 |g number:6 |g day:01 |g month:06 |g pages:442-449 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/EJA.0000000000001829 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2023 |e 6 |b 01 |c 06 |h 442-449 |